rTMS with different frequencies has been shown to regulate the expression of GFAP (a cytoskeletal marker of astrocytic reactivity) and the density of GFAP-positive astrocytes in various in vivo brain injury or disease model, such as cortical stab injury, Parkinson’s disease, etc (130–132). The gene discussed is GFAP; the disease is Parkinson disease.